Key terms
About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest MRNA news
Today
3:07am ET
Maintaining Sell Rating on Moderna Amid Financial Strains and Competitive Pressures
Yesterday
8:00am ET
Analysts Are Bullish on Top Healthcare Stocks: Moderna (MRNA), Altimmune (ALT)
Yesterday
7:55am ET
Buy Rating Affirmed for Moderna Amid Strategic Partnerships and Promising Vaccine Pipeline
Yesterday
7:05am ET
Balancing Scientific Progress with Market Realities: Moderna’s Hold Rating Explained
Yesterday
7:00am ET
Analysts Offer Insights on Healthcare Companies: Integer Holdings (ITGR), Akebia Therapeutics (AKBA) and Moderna (MRNA)
Yesterday
6:35am ET
RBC Capital Sticks to Its Buy Rating for Moderna (MRNA)
Yesterday
5:55am ET
Moderna’s Promising Vaccine Pipeline Balanced with Near-Term Caution: Hold Rating Maintained
Yesterday
5:01am ET
Analysts Offer Insights on Healthcare Companies: Moderna (MRNA), Argenx Se (ARGX) and NovoCure (NVCR)
Mar 27
8:45am ET
Moderna to host investor event
Mar 27
6:39am ET
Moderna advances multiple vaccine programs to clinical trials
Mar 27
6:37am ET
Blackstone to provide up to $750M to fund Moderna’s influenza program
Mar 27
5:55am ET
Moderna to host investor event
Mar 26
5:19pm ET
Moderna to host investor event
Mar 26
10:41am ET
Moderna’s Next-Gen COVID Vaccine Triumphs in Trial
Mar 25
9:56am ET
Early notable gainers among liquid option names on March 25th
Mar 19
8:11am ET
Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO), Moderna (MRNA) and Monte Rosa Therapeutics (GLUE)
Mar 19
12:19am ET
Novavax (NASDAQ:NVAX): A Highly Speculative Value Trade in the Post-Pandemic Era
Mar 18
8:16pm ET
Cathie Wood’s ARK Investment bought 151K shares of Moderna today
Mar 14
11:01am ET
Biotech Alert: Searches spiking for these stocks today
Mar 13
11:07am ET
Biotech Alert: Searches spiking for these stocks today
Mar 12
12:25pm ET
Moderna, Merck start two randomized trial in cancers, says RBC Capital
Mar 12
3:36am ET
Here’s What Pulled Moderna Stock (NASDAQ:MRNA) Higher Yesterday
Mar 11
8:09pm ET
Cathie Wood’s ARK Investment bought 266K shares of Moderna today
Mar 11
1:30pm ET
RBC likes Moderna, Merck cancer vaccine trial approach
Mar 11
9:55am ET
Early notable gainers among liquid option names on March 11th
Mar 06
3:25pm ET
Moderna call volume above normal and directionally bullish
Mar 06
12:07am ET
QQQ ETF Update, 3/6/2024
Mar 01
2:01pm ET
Buy/Sell: Wall Street’s top 10 stock calls this week
Mar 01
2:01pm ET
Buy/Sell: Wall Street’s top 10 stock calls this week
Mar 01
8:40am ET
Analysts Are Bullish on These Healthcare Stocks: Tenet Healthcare (THC), Moderna (MRNA)
Mar 01
8:00am ET
Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA), Moderna (MRNA) and Madrigal Pharmaceuticals (MDGL)
Yesterday
8:30am ET
Bull Market Buys: 3 Dividend Stocks to Own for the Long Run
Yesterday
5:55am ET
Better Cathie Wood Stock: Moderna vs. Intellia
Mar 23
5:50am ET
A Bull Market Is Here: 2 Magnificent Stocks Down 30% or More to Buy Right Now
Mar 23
3:46am ET
Artificial Intelligence (AI) in Healthcare: 2 Top Stock Picks
Mar 18
6:50am ET
Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought Last Week
Mar 13
6:12am ET
Moderna Stock: Bull vs. Bear
Mar 11
8:53am ET
1 (Bad) Reason to Sell Moderna Stock Right Now, and 2 Good Reasons to Buy It
MRNA Financials
Key terms
Ad Feedback
MRNA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
MRNA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range